FDA Inspection
Niagara Pharmaceuticals IncFDA Inspection 1167881 - Niagara Pharmaceuticals Inc - April 25, 2022
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
This FDA Inspection record concerns Niagara Pharmaceuticals Inc, with an inspection on April 25, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
Open in Dashboard
ID · ab045d3c-45f7-4c1d-86c2-6d21f4cb8a72
Violation Codes4
21 CFR 211.100(a)21 CFR 211.10321 CFR 211.22(d)21 CFR 211.84(b)
Full citation text and observation details available on the Dashboard.